Xconomy National

Archives

by in

Entry	Author	Date	Location
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs	Arlene Weintraub	01/26/12	Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors	Bruce V. Bigelow	04/27/11	San Diego
HemaQuest Pockets Full $12M to Treat Sickle Cell and Other Blood Disorders	Luke Timmerman	04/21/10	Seattle
Paul Allen Diagnosed with Cancer	Luke Timmerman & Gregory T. Huang	11/16/09	Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News	Luke Timmerman	10/08/09	Seattle
Seattle Genetics Shares Drop on Halted Lymphoma Trial	Luke Timmerman	10/05/09	Seattle
Genzyme’s Mozobil Gets European Approval	Ryan McBride	08/05/09	Boston
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants	Ryan McBride	05/27/09	San Diego
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009	Luke Timmerman	04/01/09	San Diego
Cell Therapeutics Reports Severe Cardiac Events in Drug Trial	Luke Timmerman	03/16/09	Seattle
Seattle Genetics Gets Orphan Drug Status	Luke Timmerman	01/26/09	Seattle
Genzyme Wins FDA Approval of Mozobil	Luke Timmerman	12/15/08	Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology	Luke Timmerman	12/09/08	National
Gloucester Drug Shrinks Tumors in Lymphoma Study	Luke Timmerman	12/08/08	Boston
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting	Luke Timmerman	12/06/08	Seattle
Zevalin Gets 6-Month FDA Review	Luke Timmerman	12/01/08	Seattle
Cell Therapeutics, Spectrum Form Joint Venture	Gregory T. Huang	11/26/08	Seattle
Cell Therapeutics Lymphoma Drug Wipes Out Tumors in Pivotal Trial	Luke Timmerman	11/11/08	Seattle
Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal	Luke Timmerman	10/16/08	Seattle
Cell Therapeutics To File for FDA Approval of Zevalin In First-Line Lymphoma	Luke Timmerman	09/22/08	Seattle
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche	Luke Timmerman	07/22/08	Boston
Page 1 of 1